Abigale Clark
Researcher
Formerly Arkansas Affiliated with UAMS through 2023; recent publications list University of Arkansas Medical Center.
Faculty Researcher
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Abigale Clark's research focuses on dermatological conditions and their treatment. Her recent publications investigate the efficacy of tofacitinib in treating sarcoidosis, review therapeutic management for keratoacanthomas, and report on pyoderma gangrenosum recurrence potentially triggered by COVID-19 vaccination. She has also published on Mohs micrographic surgery for dermatofibrosarcoma protuberans, severe cutaneous adverse reactions to lamotrigine, patient perspectives on granuloma annulare, olaparib-induced pseudoporphyria, and minocycline-induced nail pigmentation. Clark's work includes a case series of 15 patients and explores patient experiences with specific conditions. Her scholarship metrics include an h-index of 5 with 149 total citations across 10 publications. She has collaborated with Blake St. Clair at the University of Arkansas for Medical Sciences on two shared publications.
Metrics
- h-index: 5
- Publications: 10
- Citations: 155
Selected Publications
-
Olaparib-induced pseudoporphyria in a patient with ovarian cancer (2023)
-
Mohs Micrographic Surgery for Dermatofibrosarcoma Protuberans in 15 Patients: The University of Arkansas for Medical Sciences Experience (2022)
Collaboration Network
Top Collaborators
- Mohs Micrographic Surgery for Dermatofibrosarcoma Protuberans in 15 Patients: The University of Arkansas for Medical Sciences Experience
- Mohs Micrographic Surgery for Dermatofibrosarcoma Protuberans in 15 Patients: The University of Arkansas for Medical Sciences Experience
- Mohs Micrographic Surgery for Dermatofibrosarcoma Protuberans in 15 Patients: The University of Arkansas for Medical Sciences Experience
- Olaparib-induced pseudoporphyria in a patient with ovarian cancer
- Olaparib-induced pseudoporphyria in a patient with ovarian cancer
- Olaparib-induced pseudoporphyria in a patient with ovarian cancer
Similar Researchers
Based on overlapping research topics